Imagion Biosystems Limited's latest marketcap:
As of 08/15/2025, Imagion Biosystems Limited's market capitalization has reached $2.4 M. According to our data, Imagion Biosystems Limited is the 46450th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 2.4 M |
| Revenue (ttm) | 1.65 M |
| Net Income (ttm) | -1,279,137 |
| Shares Out | 0 |
| EPS (ttm) | -0.03 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/28/2025 |
Imagion Biosystems Limited's yearly market capitalization.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 08/15/2025 | $2.4 M | -15.74% | 46450 |
| 12/31/2024 | $2.87 M | -63.72% | 47530 |
| 12/29/2023 | $7.9 M | -56.81% | 45860 |
| 12/30/2022 | $18.29 M | -70.47% | 44141 |
| 12/31/2021 | $61.95 M | -44.53% | 42139 |
| 12/31/2020 | $111.68 M | 1143.69% | 38958 |
| 12/31/2019 | $8.98 M | 31.97% | 36305 |
| 12/27/2018 | $6.8 M | -61.14% | 34938 |
| 12/29/2017 | $17.51 M | 33440 |
Company Profile
About Imagion Biosystems Limited
Imagion Biosystems Limited is a pioneering medical imaging company specializing in magnetic resonance technologies. The company focuses on innovative solutions in nanotechnology, biotechnology, and cancer diagnostics.
Key Technologies & Developments
- MagSense: A breakthrough imaging technology that completed Phase 1 trials for HER2 breast cancer treatment. Research and development efforts are also underway for prostate and ovarian cancer applications.
- PrecisionMRX: An advanced iron oxide nanoparticle designed for highly accurate cancer detection.
Strategic Collaborations
The company collaborates with Siemens MRI to support Phase 2 studies of the MagSense HER2 imaging agent, enhancing its potential for clinical use.
Company Background
Founded in 2016, Imagion Biosystems Limited is headquartered in South Melbourne, Australia, driving innovation in medical diagnostics and imaging.
Frequently Asked Questions
-
What is Imagion Biosystems Limited's (OTC-IBXXF) current market cap?As of 08/15/2025, Imagion Biosystems Limited (including the parent company, if applicable) has an estimated market capitalization of $2.4 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Imagion Biosystems Limited (OTC-IBXXF) rank globally by market cap?Imagion Biosystems Limited global market capitalization ranking is approximately 46450 as of 08/15/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.